Skip to main content

Market Overview

65 Biggest Movers From Yesterday

Share:
65 Biggest Movers From Yesterday

Gainers

  • ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.
  • Takung Art Co., Ltd. (NASDAQ: TKAT) surged 24.2% to close at $39.11
  • JAKKS Pacific, Inc. (NASDAQ: JAKK) gained 23.4% to close at $9.05 after the company reported better-than-expected Q1 results.
  • Galera Therapeutics, Inc. (NASDAQ: GRTX) climbed 22.8% to settle at $8.12 after the company announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) gained 22.7% to close at $19.16. Ocular Therapeutix, reported multiple scientific presentations at the Association for Research in Vision and Ophthalmology Annual Meeting.
  • 1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) jumped 20.5% to close at $29.89 after the company reported better-than-expected Q3 results.
  • Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) gained 19.6% to close at $12.25 on Thursday.
  • SkyWater Technology, Inc. (NASDAQ: SKYT) rose 16.9% to close at $21.77. The company, last week, priced its IPO at $14 per share.
  • VEREIT, Inc. (NYSE: VER) jumped 16% to close at $47.88 after the company announced an all-stock merger agreement with Realty Income.
  • MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) gained 15.2% to close at $10.31.
  • Sharps Compliance Corp. (NASDAQ: SMED) surged 15% to close at $18.41 on continued upward momentum after the company reported better-than-expected Q3 EPS and sales results. Following earnings, HC Wainwright & Co maintained a Buy and raised its price target from $18 to $25.
  • Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares jumped 14.9% to close at $4.54 after the company signed exclusive worldwide license agreement with Johns Hopkins University to include engineered exosomes for vaccines and therapeutics as part of the company's exosome technology portfolio.
  • Communications Systems, Inc. (NASDAQ: JCS) gained 14.5% to close at $6.73 as the company agreed to sell its Transition Networks and Net2Edge businesses to Lantronix.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) surged 14.2% to settle at $12.10.
  • Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares rose 13.2% to close at $12.99. Dolphin Entertainment recently reported better-than-expected Q4 sales results.
  • Century Communities, Inc. (NYSE: CCS) gained 13.1% to settle at $74.94 after the company reported better-than-expected Q1 EPS and sales results. The company also raised its FY21 sales guidance.
  • GreenBox POS (NASDAQ: GBOX) surged 13.1% to close at $11.35.
  • North American Construction Group Ltd. (NYSE: NOA) gained 12.5% to close at $13.28 after the company reported Q1 earnings results.
  • Extreme Networks, Inc. (NASDAQ: EXTR) climbed 12.4% to close at $12.01. The company recently reported better-than-expected Q3 results.
  • Summer Infant, Inc. (NASDAQ: SUMR) gained 12% to settle at $18.91.
  • Nokia Corporation (NYSE: NOK) shares jumped 11.2% to close at $4.67 after reporting upbeat Q1 results.
  • Realogy Holdings Corp. (NYSE: RLGY) climbed 10.4% to close at $16.83 following upbeat quarterly results.
  • Alliance Data Systems Corporation (NYSE: ADS) jumped 10% to close at $118.64 following upbeat Q1 results.
  • Vaxart, Inc. (NASDAQ: VXRT) climbed 9.1% to settle at $9.21 as the company said its founder and chief scientific officer, Sean Tucker, Ph.D., will present at the World Vaccine Congress Washington that will be held virtually from May 4-6, 2021.
  • Bloomin' Brands, Inc. (NASDAQ: BLMN) rose 8.9% to settle at $31.38 after the company reported better-than-expected Q1 results.
  • MRC Global Inc. (NYSE: MRC) surged 8.9% to close at $9.87. The company recently released Q1 results.
  • AtriCure, Inc. (NASDAQ: ATRC) gained 8.8% to close at $76.00 after the company reported that its EPi-Sense System was approved by the FDA for treatment of long-standing persistent afib patients.
  • Facebook, Inc. (NASDAQ: FB) rose 7.3% to close at $329.51 after the company reported upbeat results for its first quarter on Wednesday. The company reported 1.88 billion daily active users, up 8% year-over-year, as well as 2.85 billion monthly active users, up 10% year-over-year.
  • Cheesecake Factory Inc (NASDAQ: CAKE) rose 7.1% to settle at $63.20 after reporting higher quarterly earnings.
  • QUALCOMM Incorporated (NASDAQ: QCOM) rose 4.5% to close at $142.68 after the company reported better-than-expected Q2 results and issued strong Q3 EPS guidance.

 

Check out these big penny stock gainers and losers

Losers

  • Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares tumbled 62.3% to close at $3.83 on Thursday after the company announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
  • Farmmi, Inc. (NASDAQ: FAMI) fell 54.7% to close at $0.3580 after the company priced its $42.0 million upsized underwritten public offering of ordinary shares.
  • Cara Therapeutics, Inc. (NASDAQ: CARA) dropped 45.4% to close at $14.07 after the company announced mixed topline results from its KARE Phase 2 dose-ranging clinical trial of oral Korsuva for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis patients. The company said the study did not meet the primary endpoint of worst-itch NRS change from baseline at week 12 or secondary endpoint of 4-point responder analysis in the intent-to-treat patient population. However, the study achieved primary endpoint of worst-itch NRS change and secondary endpoint of 4-point responder analysis in pre-specified analyses of mild-to-moderate AD patients, comprising 64% of ITT population.
  • Atomera Incorporated (NASDAQ: ATOM) fell 24.8% to close at $16.68 after the company reported Q1 earnings results.
  • Palisade Bio, Inc. (NASDAQ: PALI) fell 23.9% to close at $7.80.
  • Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) dipped 21.8% to close at $34.22. Brooklyn ImmunoTherapeutics acquired license for mRNA technology platform of Factor Bioscience Limited And Novellus Therapeutics Limited.
  • Brightcove Inc. (NASDAQ: BCOV) dipped 20% to settle at $15.56 after the company issued Q2 EPS and sales guidance below estimates.
  • Tiptree Inc. (NASDAQ: TIPT) fell 19.5% to close at $10.10 after the company reported it has decided to withdraw the registration statement relating to previously announced IPO by Fortegra due to ‘prevailing market conditions and the high value.’
  • Impinj, Inc. (NASDAQ: PI) dropped 19.4% to settle at $46.81 after reporting a decline in quarterly earnings.
  • Vyant Bio, Inc. (NASDAQ: VYNT) fell 19.1% to close at $3.76 after climbing 16% on Wednesday. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
  • Selecta Biosciences, Inc. (NASDAQ: SELB) dipped 19% to close at $3.15. Based on an internal strategic review and prioritization of its portfolio, Asklepios BioPharmaceutical Inc (AskBio) has decided to give all rights of methylmalonic acidemia (MMA) to Selecta Biosciences.
  • FormFactor, Inc. (NASDAQ: FORM) fell 18.2% to close at $39.22 after the company reported worse-than-expected Q1 EPS results.
  • Regional Health Properties, Inc. (NYSE: RHE) dropped 17.9% to close at $5.23.
  • Galectin Therapeutics Inc. (NASDAQ: GALT) shares fell 16.9% to settle at $4.24 after jumping over 22% on Wednesday. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company's galectin-3 inhibitor, belapectin.
  • Cohu, Inc. (NASDAQ: COHU) dipped 16.9% to close at $38.85 after reporting Q1 results.
  • 22nd Century Group, Inc. (NYSE: XXII) fell 15.7% to settle at $4.74.
  • Resolute Forest Products Inc. (NYSE: RFP) fell 15.4% to close at $13.17 after reporting preliminary Q1 results.
  • Coeur Mining, Inc. (NYSE: CDE) dropped 14.4% to settle at $8.23 after the company reported worse-than-expected Q1 EPS and sales results.
  • Aurora Mobile Limited (NASDAQ: JG) fell 14.3% to close at $3.61.
  • MicroVision, Inc. (NASDAQ: MVIS) dipped 14.2% to close at $18.00.
  • Aspen Technology, Inc. (NASDAQ: AZPN) fell 13.2% to settle at $132.64 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY21 EPS and sales guidance below analyst estimates.
  • Cree, Inc. (NASDAQ: CREE) fell 12.6% to close at $98.53 after the company issued Q4 EPS guidance below analyst estimates. JP Morgan also downgraded the stock from Neutral to Underweight.
  • Nemaura Medical Inc. (NASDAQ: NMRD) fell 12.6% to close at $4.73.
  • Smart Share Global Limited (NASDAQ: EM) dropped 12.5% to settle at $8.06.
  • Ribbon Communications Inc. (NASDAQ: RBBN) dipped 11.9% to close at $7.17 following weak quarterly sales.
  • eBay Inc. (NASDAQ: EBAY) fell 10% to settle at $56.07. eBay reported upbeat Q1 earnings, but issued weak earnings guidance for the current quarter.
  • Lyft, Inc. (NASDAQ: LYFT) fell 9.9% to close at $57.10 on reports the US Labor Secretary said most US gig workers should be classified as employees.
  • Ford Motor Company (NYSE: F) fell 9.4% to close at $11.26 after the company reported Q1 earnings results.
  • ServiceNow, Inc. (NYSE: NOW) fell 9.4% to settle at $505.00 after the company reported Q1 earnings results.
  • Peabody Energy Corporation (NYSE: BTU) dropped 9.3% to close at $3.89 following quarterly results.
  • Hologic, Inc. (NASDAQ: HOLX) fell 8.5% to settle at $66.23 after the company reported worse-than-expected Q2 results and issued weak Q3 guidance.
  • Teladoc Health, Inc. (NASDAQ: TDOC) fell 8.3% to close at $170.86 after reporting Q1 results.
  • American Shared Hospital Services (NYSE: AMS) dropped 8.3% to close at $2.44.
  • Citrix Systems, Inc. (NASDAQ: CTXS) dropped 7.6% to close at $128.02 after the company reported worse-than-expected Q1 results.
  • Tenaris S.A. (NYSE: TS) fell 7.2% to close at $21.02 after the company reported Q1 results.
 

Related Articles (ADS + ADVM)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com